Gianfabio Giorgioni
16PUBLICATIONS
40CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Mar 29, 2025
New Arylpiperazines as Potent and Selective Dopamine D4 Receptor Ligands Potentially Useful to Treat Glioblastoma.Federica Matteucci, Pegi Pavletić, Alessandro Bonifazi
|Jun 27, 2024
Synthesis, Biological, and Computational Evaluations of Conformationally Restricted NAD-Mimics as Discriminant Inhibitors of Human NMN-Adenylyltransferase Isozymes.Federica Matteucci, Marta Ferrati, Eleonora Spinozzi
|Jun 04, 2024
Copper-Based Complexes with Adamantane Ring-Conjugated bis(3,5-Dimethyl-pyrazol-1-yl)acetate Ligand as Promising Agents for the Treatment of Glioblastoma.Maria Beatrice Morelli, Miriam Caviglia, Carlo Santini
|Jun 01, 2023
Properly Substituted Benzimidazoles as a New Promising Class of Nicotinate Phosphoribosyltransferase (NAPRT) Modulators.Cecilia Baldassarri, Gianfabio Giorgioni, Alessandro Piergentili
|Apr 10, 2023
Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.Alessandro Bonifazi, Fabio Del Bello, Gianfabio Giorgioni
|Sep 13, 2022
Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.Pegi Pavletić, Ana Semeano, Hideaki Yano
Pageof 3
Frequent Collaborators
14 joint publications
Fabio Del Bello
11 joint publications
Alessandro Piergentili
11 joint publications
Wilma Quaglia
7 joint publications
Alessandro Bonifazi
6 joint publications
Giulio Vistoli
5 joint publications
Carlo Cifani
5 joint publications
Maria Vittoria Micioni Di Bonaventura
4 joint publications
Luca Botticelli
4 joint publications
Emanuela Micioni Di Bonaventura
4 joint publications
Loredana Cappellacci
